1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
CTT Pharmaceutical Holdings, Inc.

CTT Pharmaceutical Holdings, Inc.

CTTH
CTT Pharmaceutical Holdings, Inc.US flagOther OTC
0.06
USD
+0.00
- -
1.30MMarket Cap
2005 Y
2006 Y
2007 Y
2008 Y
2009 Y
2010 Y
2011 Y
2012 Y
2013 Y
2014 Y
2015 Y
2024 Y
2025 Y
TTM
Revenue per Share
- -
0.01
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
-3.31
-2.16
-4.33
-2.27
-2
-1.3
4.19
-1.07
- -
0.14
-0.07
- -
- -
- -
Free Cash Flow per Basic Share
-3.16
-1.15
-2.31
-0.87
-0.36
-1.98
-0.35
-1.09
- -
-0.04
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-7.4
-9.24
-12.75
-13.95
-13.94
-14.68
-13.42
-13.83
-0.01
-0.53
-0.11
-0.14
-0.13
-0.13
Tangible Book Value per Share
0.13
1.31
0.87
0.22
-1.53
- -
0.51
-0.41
- -
0.91
0.02
- -
- -
- -
Basic Weighted Avg Shares
1
1
1
1
1
1
1
1
15
2
21
52
58
59
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
-242,663.03
-41,310.13
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-2
-1
-3
-2
-2
-1
4
-1
- -
- -
-1
- -
- -
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-242,660.39
-41,302.11
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Working Capital
- -
- -
- -
-1
-2
- -
-3
- -
- -
1
- -
- -
- -
- -
LT Debt
2
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
1
1
- -
-1
- -
- -
- -
- -
1
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
-249.4
- -
- -
-91.85
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
-31.22
- -
- -
-43.02
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
58
59
60
Market Capitalization
3
3
4

Working Capital

FRC

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2,714.88%
-1,076.07%
71.36%
Free Cash Flow
3,632.19%
7,161.99%
-65.06%
Net Income, GAAP
-289.76%
-451.58%
-37.69%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Ryan Khouri
Full Time Employees
1
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Address
3853 Northdale Blvd Tampa FL United States of America 33624
IPO Date
Apr 18, 1997
CIK
0001035422
Website
cttpharmaceuticals.com
Similar Companies
Almujtama Alraida Medical Co. (9592.SR)
Islet Holdings, Inc. (ISHI)
Add-Shop E-Retail Limited (ASRL.BO)
Endo International plc (0Y5F.L)
Targeted Medical Pharma, Inc. (TRGM)
Immunovia AB (0G8X.L)
Business
CTT Pharmaceutical Holdings, Inc. CTT Pharmaceutical Holdings, Inc. is a development-stage biopharmaceutical company that develops innovative oral thin-film drug delivery systems for pain management, chronic disease treatment, smoking cessation, and veterinary applications. Its core technology platform centers on proprietary fast-dissolving wafers, including MedWAFE for reducing opioid dosages and addiction risks in humans; CannaWAFE for controlled-dosage cannabis extracts such as THC and CBD as smoke-free alternatives; VetWAFE for pain relief in dogs and cats; and dissolvable nicotine strips designed to deliver lower doses faster than gums or lozenges to aid quitting. The company, founded in 2013 and headquartered in Tampa, Florida, operates principally in the United States and Canada through its wholly owned subsidiary CTT Pharmaceuticals Inc., with a focus on narcotics, opiates, cannabinoids, and vitamins delivered via saliva-activated polymer films that enhance bioavailability without water. Recent developments include uplisting to the OTCQB market in March 2025; signing a $3 million equity line of credit in September 2025 to fund manufacturing and pursue SEC reporting status; submitting a $15 million NIH grant proposal with Johns Hopkins University in early 2025 for clinical trials of its smoking cessation nicotine strips, with review outcomes pending; entering a business development partnership with 3 Rivers Biotech; appointing Ryan Khouri as CEO; securing patent approval in Israel for its dissolvable strip technology; and completing PCAOB audits for 2024 to support three years of compliant financials.

Company News

APIChatGPT

  • thenewswire.com

    CTT Pharma Signs LOI with European Company

  • accessnewswire.com

    CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones

  • accessnewswire.com

    CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics

  • thenewswire.com

    CTT Pharma's CEO will issue a Letter to Shareholders

  • thenewswire.com

    CTT Pharma Signs Contract for $3 Million Equity Line of Credit